Webinare

Exploring Circulating Extracellular Vesicles in Liquid Biopsies for Neurological Disorders

18 Apr 2024

Wednesday, 24 April 2024
03.00 p.m. (GTM +2)

Tags: Next-Generation Sequencing, NGS, webinar, EVs, neuroscience research, cell-free biomarker

Level Up Your MRD Testing: Leveraging Standardized & Sensitive AML Assessments

14 Mar 2024

on demand

Tags: Invivoscribe, Next-Generation Sequencing, NGS, webinar, MRD, LymphoTrack® , AML

NGS-based MRD Testing for Acute Lymphoblastic Leukemia

8 Nov 2022

Tuesday, 11/15/2022
7.00 - 8.00 pm CET

Tags: Invivoscribe, Leukemia , Leukämie, Lymphoid Malignancies, Next-Generation Sequencing, NGS, Klonalität , Clonality , IVS, webinar, B-Zellen, B-cells, MRD, LymphoTrack®

Next-Generation Sequencing of Immunoglobulin Genes in Lymphoid Malignancies

5 May 2022

Identify genes targeted for clonality assessment in B-cell malignancies
Compare sequencing techniques used for immunoglobulin genes
Describe pre-analytical variables that impact immunoglobulin sequencing
Contrast clonality analysis by next-generation sequencing to traditional non-sequencing methods

Tags: Invivoscribe, Leukemia , Leukämie, Lymphoid Malignancies, Next-Generation Sequencing, NGS, Klonalität , Clonality , IVS, webinar, B-Zellen, B-cells

IVDR compliant use of LDTs in the laboratory

8 Mar 2022

The IVDR comes into effect on 5/25/2022 and provides new rules for homegrown tests (homebrew/LDTs)
Dr. Andreas Eckelt (IVDRconsulting)

Tags: LGC Clinical Diagnostics, Reference Materials, Seraseq, LGC Seracare, Referenzmaterial, Oncology, NIPT, NGS, CE-IVD, IVDR, DNA Diagnostics, HiSS Diagnostics Solution, LDT, Laboratory Developed Tests

Review of Guidelines for Interpreting Somatic Hypermutation Status

26 Jan 2022

in Chronic Lymphocytic Leukemia in the Era of High-Throughput Sequencing

Tags: CLL, SHM status , chronic lymphocytic leukemia, somatic hypermutation , next-generation sequencing , NGS, IVS, Invivoscribe